La., has proposed ways to modernize the Food and Drug Administration in a new report. “While many parts of FDA work well, unnecessary bottlenecks slow patients and consumers ...
Cassidy is reacting to criticism from drug manufacturers of the review process, which he argues makes medicine more expensive.